The announcement comes less than a year after Virgin Pulse and HealthComp announced their $3 billion merger and their rebranding as Personify Health.

The Agency has qualified Apple's atrial fibrillation history feature as a medical device development tool, allowing it to be used in clinical trials.

Also, Clanwilliam has formally established its ANZ division.

The open-source gene editor is freely available to license for commercial use and ethical research.

The Agency alleges the company's CT and ultrasonography systems are noncompliant with good manufacturing requirements.

The company will use the funds to accelerate its AI capabilities and for strategic and commercial growth.